Association of PvuII and XbaI polymorphisms on estrogen receptor alpha (ESR1) gene to changes into serum lipid profile of post-menopausal women: Effects of aging, body mass index and breast cancer incidence

PLoS One. 2017 Feb 15;12(2):e0169266. doi: 10.1371/journal.pone.0169266. eCollection 2017.

Abstract

Estrogen is a steroidal hormone involved in several physiological functions in the female body including regulation of serum lipid metabolism and breast cancer (BC). Estrogen actions on serum lipids mostly occur through its binding to intracellular Estrogen Receptor alpha (ERalpha) isoform, expressed in most of tissues. This gene (ESR1) exhibit many polymorphic sites (SNPs) located either on translated and non-translated regions that regulate ERalpha protein expression and function. This paper aimed to investigate the association of two intronic SNPs of ESR1 gene, namely c454-397T>C (PvuII) and c454-351A>G (XbaI) to alterations in serum levels of total cholesterol (T-chol), total lipid (TL), low density lipoprotein cholesterol (LDL), high density lipoprotein (HDL), and triglycerides (TG) in a cohort of post-menopausal women. In addition, we aimed to associate presence of these SNPs to development of BC along 5 years period. To do so, a group of healthy 499, highly miscigenated, post-menopausal Brazilian women, were carried using PCR-FRLP technique and further confirmed by automatic sequence analysis as well followed through 5 years for BC incidence. Measurements of serum lipid profile by standard commercial methods were carried individually whereas Dual Energy X-ray Absorciometry (DXA) measured Body Mass Indexes (BMI), Fat Mass (FM), Lean Body Mass (LBM), and Body Water Content (BWC). No effects of PvuII SNP on ESR1 gene were observed on patient´s serum T-chol, TL, LDL, HDL, and TG. However, c454-397T>C PvuII SNP is associated to lower body fat and higher levels of lean mass and body water and lower incidence of BC. On the other hand, statistically significant effect of XbaI c454-351A>G SNP on serum TG and TL levels. Patients homozygous for X allele were followed up from 2010-2015. They showed higher incidence of breast cancer (BC) when compared to either heterozygous and any P allele combination. Moreover, the increasing of TG and TL serum concentrations associated to SNP XbaI c454-351A>G on ESR1 gene is enhanced in both obese (higher BMI) and elder women. Taken together, these results suggested that XbaI c454-351A>G SNP is associated to changes in lipid profile, particularly in serum TG and TL, in this cohort of post-menopausal woman. Also, this paper shows another link between obesity and BC corroborating the current thesis that both diseases are interlinked.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging
  • Body Mass Index*
  • Breast Neoplasms* / blood
  • Breast Neoplasms* / genetics
  • Deoxyribonucleases, Type II Site-Specific
  • Estrogen Receptor alpha / genetics*
  • Estrogen Receptor alpha / metabolism
  • Female
  • Humans
  • Incidence
  • Lipids / blood*
  • Lipids / genetics
  • Middle Aged
  • Obesity* / blood
  • Obesity* / genetics
  • Polymorphism, Single Nucleotide*
  • Postmenopause* / blood
  • Postmenopause* / genetics

Substances

  • ESR1 protein, human
  • Estrogen Receptor alpha
  • Lipids
  • endodeoxyribonuclease XBAI
  • Deoxyribonucleases, Type II Site-Specific

Grants and funding

The authors thank FACITEC [no. 017/2006 and no. 036/2006], FAPES [no. 172.1/2005], DECIT-SUS [no. 31614990/2005] and CNPq [no. 480807/2006] for financial support. The authors would also gratefully acknowledge the Centro de Diagnóstico e Pesquisa da Osteoporose do Espírito Santo – CEDOES (Vitória/ES, Brazil) and Instituto Tommasi de Pesquisa e Desenvolvimento (Vila Velha, Brazil). www.cnpq.br, www.fapes.es.gov.br, www.facitec.ivx.es.gov.brNo.